Korea Investment Corp Sarepta Therapeutics, Inc. Transaction History

Korea Investment Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$77.28 - $99.42 $11.3 Million - $14.6 Million	-146,841 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $1.55 Million - $2.17 Million	-23,500 Reduced 13.8%	146,841 $13.6 Million
Q2 2021 Aug 12, 2021	SELL	$69.38 - $86.75 $1.42 Million - $1.78 Million	-20,500 Reduced 10.74%	170,341 $13.2 Million
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $997,050 - $2.33 Million	-13,800 Reduced 6.74%	190,841 $14.2 Million
Q4 2020 Feb 10, 2021	BUY	$125.56 - $178.74 $2.32 Million - $3.31 Million	18,500 Added 9.94%	204,641 $34.9 Million
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $2.24 Million - $3.03 Million	-17,600 Reduced 8.64%	186,141 $26.1 Million
Q2 2020 Aug 12, 2020	BUY	$93.0 - $171.7 $372,000 - $686,800	4,000 Added 2.0%	203,741 $32.7 Million
Q1 2020 May 14, 2020	BUY	$82.38 - $131.64 $2.5 Million - $4 Million	30,400 Added 17.95%	199,741 $19.5 Million
Q4 2019 Feb 11, 2020	BUY	$76.53 - $135.58 $505,098 - $894,828	6,600 Added 4.06%	169,341 $21.9 Million
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $9.13 Million - $19.7 Million	125,441 Added 336.3%	162,741 $12.3 Million
Q2 2019 Aug 12, 2019	SELL	$112.21 - $151.95 $381,514 - $516,629	-3,400 Reduced 8.35%	37,300 $5.67 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $2.17 Million - $3.08 Million	20,300 Added 99.51%	40,700 $4.85 Million
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $2.35 Million - $3.29 Million	20,400 New	20,400 $3.3 Million

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Korea Investment Corp with notifications on news.